NCT00386347

A Study To Evaluate Formulations And Food Effect On GSK364735 In Healthy Subjects.

A Single Dose, Randomized, 5-Period, Balanced, Crossover Study to Assess the Relative Bioavailability of Three Formulations and Food Effect on GSK364735 and Pharmacokinetics Following a Double Blind, Placebo Controlled, Repeat Dose Administration to Healthy Subjects.

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 56 (planned)
• Sponsor: GlaxoSmithKline · Industry
• Sex: All
• Age: 18 Years – 55 Years
• Healthy volunteers: Accepted

Summary

This study is a two-part study. Part one is designed to see how different formulations of GSK364735 are absorbed in the body and To see how food affects how GSK364735 is absorbed in the body. Part two is designed to see how repeat dosing affects how GSK364735 is absorbed in the body.

Conditions

• HIV Infection
• Infection, Human Immunodeficiency Virus

Interventions

Type	Name	Description
DRUG	GSK364735 oral solution and oral tablets

Timeline

• Start date: 2006-10-01
• First posted: 2006-10-11
• Last updated: 2012-06-04

Locations

1 site across 1 country: United States